Skip to main content

Find Clinical Trials

Home
Conditions
Nasopharyngeal Carcinoma

Clinical trial condition

Nasopharyngeal Carcinoma

Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

377 public trials 137 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Carcinoma trial results

Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +62 more
Locations: Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States

Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States

Arizona Center for Cancer Care - Phoenix Phoenix, Arizona, United States

Arizona Center for Cancer Care - Scottsdale Scottsdale, Arizona, United States

View all 153 locations

View Trial Details

Recruiting

Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma

NCT07762976

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Fudan Universtiy Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

NCT07749586

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +92 more
Locations: Clinical Trial Site Huntersville, North Carolina, United States

Clinical Trial Site San Antonio, Texas, United States

Clinical Trial Site Fairfax, Virginia, United States

View Trial Details

Recruiting

A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

NCT06475300

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +21 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma

NCT07706985

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

NCT06662058

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +54 more
Locations: Emory Midtown University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

NCT01365169

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +89 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

NCT06592599

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

NCT06017895

Conditions: Carcinoma, Head and Neck Neoplasms, Mouth Diseases, +14 more
Locations: Southern medical university Guangzhou, Guangdong, China

View Trial Details

Recruiting

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

NCT06682442

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details